Business Wire

CA-BIOCYTOGEN

Share
Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Biosciences

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an antibody evaluation and option agreement with Neurocrine Biosciences, Inc. The agreement grants Neurocrine Biosciences access to Biocytogen’s fully human antibodies against multiple specified targets, with an option to license selected antibodies for therapeutic product development, manufacturing and commercialization for all uses worldwide. Additional targets may be included under this agreement subject to mutual agreement. The antibodies were generated by Biocytogen’s proprietary RenMice® platforms.

Under the terms of the agreement, if options are exercised, Biocytogen will be entitled to option-exercise fees, development and commercialization milestone payments, as well as single-digit royalties on net sales for each selected target.

Dr. Yuelei Shen, President and CEO of Biocytogen, said, “We are pleased that our RenMice®-derived fully human antibodies received recognition from Neurocrine Biosciences, a world-leading neuroscience-focused biopharmaceutical company. We are optimistic that the combination of our comprehensive, validated off-the-shelf antibody sequences and Neurocrine’s extensive experience in novel drug development will accelerate the path to help conquer neurological diseases that are difficult to treat.”

“We are excited to evaluate the therapeutic potential of antibodies generated from Biocytogen’s renowned fully human antibody platforms,” said Jude Onyia, Ph.D., Chief Scientific Officer at Neurocrine Biosciences. “We believe this collaboration will help expand our pipeline with antibody-based drugs and ultimately provide patients with improved treatment options.”

About Biocytogen

Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMabTM/RenLite®/RenNano®/RenTCR-mimicTM) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. As of June 30, 2023, 50 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and 42 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMiceTM, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco), and Germany (Heidelberg). For more information, please visit http://en.biocytogen.com.cn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231219983706/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Games of the Future 2025 Set to Bring the World Together in UAE for the Next Generation of Sport24.10.2025 11:34:00 CEST | Press release

Abu Dhabi, UAE will host the Games of the Future 2025 (GOTF 2025), the groundbreaking global event where phygital sports bring together elite clubs, athletes, and gamers to compete in cutting-edge disciplines that blend real-world athleticism with advanced gaming technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251024640292/en/ Games of The Future Highlights Community, Innovation and Youth Empowerment (Photo: AETOSWire) Taking place from 18-23 December 2025 at ADNEC Centre Abu Dhabi, the tournament is a natural extension of the ‘We the UAE 2031’ vision and the nation’s designation of 2025 as the Year of Community, reinforcing the UAE's role as a global hub for sport, innovation, youth empowerment, and cultural exchange. His Excellency Dr. Ahmad Belhoul Al Falasi, UAE Minister of Sports, affirmed that Abu Dhabi's hosting of the Games of the Future 2025 is a qualitative new step in the country's journey to consolidat

Thales Named Frost & Sullivan’s 2025 Company of the Year in Automated Border Control24.10.2025 08:00:00 CEST | Press release

Thales, a global leader in cybersecurity and identity management, has been recognized by Frost & Sullivan as Company of the Year 2025 in the Automated Border Control (ABC) eGates industry.This award underscores Thales’s ability to consistently innovate, deliver scalable and sustainable solutions, and set new standards for border security and passenger experience worldwide.Frost & Sullivan emphasized Thales’s proven ability to deliver at scale, its close collaboration with ministries of interior and airport operators, and its forward-looking strategy that integrates regulatory compliance, digital identity, and sustainability. As governments and airports face rising passenger volumes, new regulatory requirements such as the European Entry Exit System (EES), and evolving security threats, Thales’s solutions help strike the right balance between strong security and traveller convenience. Frost & Sullivan praised Thales’s end-to-end expertise, customer focus, and ability to design systems t

NTT DOCOMO BUSINESS and NTT Com Asia Launch “APN InterLink” Service in Hong Kong24.10.2025 06:00:00 CEST | Press release

Transforming the Financial Services Industry with IOWN® Infrastructure NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation, hereafter “NTT DOCOMO BUSINESS”) and its Hong Kong subsidiary, NTT Com Asia, today announced the launch of the “APN InterLink” service in Hong Kong for financial institutions starting November 1, 2025, leveraging All-Photonic Network (APN)*1 technology in support of the IOWN®*2 initiative. Commercially deployed in Hong Kong, one of the leading Asia financial hubs, the new service leverages ultra-low latency photonics-based connectivity to address the evolving digital needs of the financial sector, especially for latency-sensitive trading, algorithmic trading*3, proximity market data access and real-time transaction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023916941/en/ NTT APN InterLink Service Looking ahead, NTT DOCOMO BUSINESS and NTT Com Asia plan to expand the deployment of

Hanshow Wins the Technology Vendor of the Year at 2025 RTIH Innovation Awards in London24.10.2025 05:00:00 CEST | Press release

Hanshow, a global leader in digital retail solutions, has been honoured at the 2025 Retail Technology Innovation Hub (RTIH) Innovation Awards, winning the Technology Vendor of the Year title for its pioneering shelf marketing solution. The recognition underscores Hanshow’s commitment to redefining how retailers and brands engage with shoppers through NFC-enabled ESLs that seamlessly connect physical stores with digital engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023122859/en/ The RTIH Innovation Awards are widely regarded as one of the most influential recognitions in the global retail technology sector. Each year, the awards celebrate organisations driving innovation, digital transformation, and operational excellence in a fast-moving omnichannel world. The 2025 ceremony, held at The HAC in central London, brought together senior retail executives, technology innovators, and thought leaders shaping the fut

DNIB.com Reports Internet Has 378.5 Million Domain Name Registrations at the End of the Third Quarter of 202523.10.2025 23:00:00 CEST | Press release

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the third quarter of 2025 closed with 378.5 million domain name registrations across all top-level domains (TLDs), an increase of 6.8 million domain name registrations, or 1.8% compared to the second quarter of 2025. Domain name registrations also increased by 16.2 million, or 4.5%, year over year. The .com and .net TLDs had a combined total of 171.9 million domain name registrations in the domain name base at the end of third quarter of 2025, an increase of 1.4 million domain name registrations, or 0.8% compared to the second quarter of 2025. The .com and .net TLDs had a combined increase of 2.4 million domain name registrations, or 1.4%, year over year. As of Sept. 30, 2025, the .com domain name base totaled 159.4 million domain name registrations and the .net do

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye